Dova Pharmaceuticals Receives Positive Opinion from CHMP for DOPTELET® (avatrombopag) for the Treatment of Thrombocytopenia in ...
DURHAM, N.C., April 29, 2019 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA) today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion for the use of DOPTELET …